Share-based Payment Arrangement, Expense in USD of bioAffinity Technologies, Inc. from 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
bioAffinity Technologies, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2021 to Q3 2025.
  • bioAffinity Technologies, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $67.1K, a 63.8% decline year-over-year.
  • bioAffinity Technologies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $839K, a 23.1% decline year-over-year.
  • bioAffinity Technologies, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $990K, a 32.2% increase from 2023.
  • bioAffinity Technologies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $749K, a 201% increase from 2022.
  • bioAffinity Technologies, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $249K, a 99.4% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

bioAffinity Technologies, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $839K $67.1K -$119K -63.8% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $958K $212K -$75.7K -26.3% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $1.03M $327K +$44K +15.6% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $990K $234K -$102K -30.3% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 $1.09M $186K +$100K +118% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 $991K $287K +$117K +68.7% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $874K $283K +$125K +79.3% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $749K $336K +$299K +811% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $450K $85.2K +$6.23K +7.89% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $444K $170K +$144K +538% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 $300K $158K +$51.6K +48.6% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $249K $36.8K 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 $79K 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $26.7K 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $106K 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023

bioAffinity Technologies, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $990K +$241K +32.2% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $749K +$500K +201% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 $249K -$42.8M -99.4% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 $43M 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.